72 results on '"Van Hemelrijck, Mieke"'
Search Results
2. ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer
3. Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
4. Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
5. Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave
6. Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19
7. Invadopodia play a role in prostate cancer progression
8. An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study
9. Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
10. Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
11. Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer
12. Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
13. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
14. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
15. The incidence and prevalence of upper tract urothelial carcinoma: a systematic review
16. Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
17. Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre
18. An assessment of the use of patient reported outcome measurements (PROMs) in cancers of the pelvic abdominal cavity: identifying oncologic benefit and an evidence-practice gap in routine clinical practice
19. The effectiveness of the Guy’s Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients
20. Cohort profile: King’s Health Partners bladder cancer biobank
21. Depression, anxiety, and suicidality in patients with prostate cancer: a systematic review and meta-analysis of observational studies
22. Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
23. Feasibility study to identify women of childbearing age at risk of pregnancy not using any contraception in The Health Improvement Network (THIN) database
24. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
25. Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review
26. Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence
27. Effect of a brief physical activity-based presentation by a former patient for men treated with radical prostatectomy for prostate cancer: a mixed methods pilot study
28. Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases
29. Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
30. Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review
31. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
32. Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
33. Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
34. Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study
35. How to measure temporal changes in care pathways for chronic diseases using health care registry data
36. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort
37. Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
38. Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study
39. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
40. The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial
41. Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
42. Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?
43. Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
44. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes
45. Serum inflammatory markers and colorectal cancer risk and survival
46. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
47. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
48. Erratum: Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
49. Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy
50. Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.